Cargando…

Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study

BACKGROUND: Lung cancer is the leading cause of cancer mortality worldwide. Even after radical resection, the rate of recurrence of non-small cell lung cancer remains high. AIM: To identify the profile of patients operated for lung cancer and to study the prognostic factors of tumor recurrence. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Slim, Azza, Kamoun, Hela, Hadidene, Yasmin, Smadhi, Hanen, Meddeb, Amani, Megdiche, Mohamed Lamine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Societe Tunisienne Des Sciences Medicales 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772599/
https://www.ncbi.nlm.nih.gov/pubmed/35244906
_version_ 1784635883167678464
author Slim, Azza
Kamoun, Hela
Hadidene, Yasmin
Smadhi, Hanen
Meddeb, Amani
Megdiche, Mohamed Lamine
author_facet Slim, Azza
Kamoun, Hela
Hadidene, Yasmin
Smadhi, Hanen
Meddeb, Amani
Megdiche, Mohamed Lamine
author_sort Slim, Azza
collection PubMed
description BACKGROUND: Lung cancer is the leading cause of cancer mortality worldwide. Even after radical resection, the rate of recurrence of non-small cell lung cancer remains high. AIM: To identify the profile of patients operated for lung cancer and to study the prognostic factors of tumor recurrence. METHODS : We performed a retrospective study including 67 cases of lung cancer with curative surgery, hospitalized between 2010 and 2016. RESULTS: The mean age was 61 years. The sex ratio was 21. The average time to diagnosis was 22 days. The average time to start treatment was 10 days. The most common histological type was adenocarcinoma (63%). Lobectomy was performed in 63% of the patients. Tumor recurrence was noted in 40% of the patients. The average time between recurrence and the surgical treatment was 12 months. The most common location of recurrence was the lung (70%). Recurrence was more common among adenocarcinoma and smokers older than 60 years. The majority of locally advanced and metastatic cancers have recurred. The average survival was 56 ± 4months. Better survival rates were observed in young patients, with less than 25 pack-years of early-stage, no lymph node involvement, and patients who received adjuvant chemotherapy. The probability of survival was 5 years for all tumor stages. CONCLUSION : The prognostic factors for recurrence after radical resection for lung cancer were: the age of patients, smoking history, histological type, tumor stage, and surgical procedure.
format Online
Article
Text
id pubmed-8772599
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Societe Tunisienne Des Sciences Medicales
record_format MEDLINE/PubMed
spelling pubmed-87725992022-05-17 Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study Slim, Azza Kamoun, Hela Hadidene, Yasmin Smadhi, Hanen Meddeb, Amani Megdiche, Mohamed Lamine Tunis Med Article BACKGROUND: Lung cancer is the leading cause of cancer mortality worldwide. Even after radical resection, the rate of recurrence of non-small cell lung cancer remains high. AIM: To identify the profile of patients operated for lung cancer and to study the prognostic factors of tumor recurrence. METHODS : We performed a retrospective study including 67 cases of lung cancer with curative surgery, hospitalized between 2010 and 2016. RESULTS: The mean age was 61 years. The sex ratio was 21. The average time to diagnosis was 22 days. The average time to start treatment was 10 days. The most common histological type was adenocarcinoma (63%). Lobectomy was performed in 63% of the patients. Tumor recurrence was noted in 40% of the patients. The average time between recurrence and the surgical treatment was 12 months. The most common location of recurrence was the lung (70%). Recurrence was more common among adenocarcinoma and smokers older than 60 years. The majority of locally advanced and metastatic cancers have recurred. The average survival was 56 ± 4months. Better survival rates were observed in young patients, with less than 25 pack-years of early-stage, no lymph node involvement, and patients who received adjuvant chemotherapy. The probability of survival was 5 years for all tumor stages. CONCLUSION : The prognostic factors for recurrence after radical resection for lung cancer were: the age of patients, smoking history, histological type, tumor stage, and surgical procedure. Societe Tunisienne Des Sciences Medicales 2021-05 2021-05-01 /pmc/articles/PMC8772599/ /pubmed/35244906 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Unported License. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Article
Slim, Azza
Kamoun, Hela
Hadidene, Yasmin
Smadhi, Hanen
Meddeb, Amani
Megdiche, Mohamed Lamine
Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title_full Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title_fullStr Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title_full_unstemmed Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title_short Postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
title_sort postoperative recurrence of primary lung cancer: anatomo-clinical and therapeutic study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772599/
https://www.ncbi.nlm.nih.gov/pubmed/35244906
work_keys_str_mv AT slimazza postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy
AT kamounhela postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy
AT hadideneyasmin postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy
AT smadhihanen postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy
AT meddebamani postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy
AT megdichemohamedlamine postoperativerecurrenceofprimarylungcanceranatomoclinicalandtherapeuticstudy